Alan Louis Urban
Chief Financial Officer · GT Biopharma, Inc.
Individual
- 2024
- Sep 4, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Alan Louis Urban's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- David Cordani - $59.11M in CI purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Steven Leonard Chapman - $58.66M in NTRA purchases and sales in the last 12 months
- Mark A. Goldsmith - $55.93M in RVMD purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alan Louis Urban?
Alan Louis Urban is a corporate insider, tracked as Chief Financial Officer of GT Biopharma, Inc. (GTBP). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Alan Louis Urban last file a Form 4?
The most recent primary Form 4 on record is dated 4 September 2025, one of 2 filings going back to 2024.